Trial Profile
Placebo-Controlled Proof of Concept Study to Investigate ANB020 Activity in Adult Patients With Severe Eosinophilic Asthma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Aug 2023
Price :
$35
*
At a glance
- Drugs Etokimab (Primary)
- Indications Asthma
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- Sponsors AnaptysBio
- 05 Jun 2019 According to an AnaptysBio media release, results from the study were presented at the 2019 European Academy of Allergy and Clinical Immunology (EAACI) Congress.
- 05 Jun 2019 Updated results presented in an AnaptysBio media release.
- 30 Jan 2019 Status changed from recruiting to completed.